Registro:

Referencias:

• Ashwell, J.D., Lu, F.W., Vacchio, M.S., Glucocorticoids in T-cell development and function (2000) Annu Rev Immunol, 18, pp. 309-345
• Sapolsky, R.M., Romero, L.M., Munck, A.U., How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions (2000) Endocr Rev, 21, pp. 55-89
• Besedovsky, H.O., del Rey, A., Immune-neuroendocrine circuits: integrative role of cytokines (1992) Front Neuroendocrinol, 13, pp. 61-94
• Boumpas, D.T., Chrousos, G.P., Wilder, R.L., Cupps, T.R., Balow, J.E., Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates (1993) Ann Intern Med, 119, pp. 1198-1208
• Barnes, P.J., Adcock, I.M., Transcription factors and asthma (1998) Eur Respir J, 12, pp. 221-234
• Swartz, S.L., Dluhy, R.G., Corticosteroids: clinical pharmacology and therapeutic use (1978) Drugs, 16, pp. 238-255
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors (2000) J Neuroimmunol, 109, pp. 16-22
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression (2003) Endocr Rev, 24, pp. 488-522
• Drouin, J., Maira, M., Philips, A., Novel mechanism of action for Nur77 and antagonism by glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription (1998) J Steroid Biochem Mol Biol, 65, pp. 59-63
• Abbas, A.K., Murphy, K.M., Sher, A., Functional diversity of helper T lymphocytes (1996) Nature, 383, pp. 787-793
• Dinarello, C.A., Mier, J.W., Lymphokines (1987) N Engl J Med, 317, pp. 940-945
• Paul, W.E., Seder, R.A., Lymphocyte responses and cytokines (1994) Cell, 76, pp. 241-251
• Wang, M., Tan, Z., Zhang, R., Kotenko, S.V., Liang, P., Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2 (2002) J Biol Chem, 277, pp. 7341-7347
• Dinarello, C.A., The interleukin-1 family: 10 years of discovery (1994) FASEB J, 8, pp. 1314-1325
• Reed, J.C., Abidi, A.H., Alpers, J.D., Hoover, R.G., Robb, R.J., Nowell, P.C., Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression (1986) J Immunol, 137, pp. 150-154
• Gillis, S., Crabtree, G.R., Smith, K.A., Glucocorticoid-induced inhibition of T-cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation (1979) J Immunol, 123, pp. 1624-1631
• Boumpas, D.T., Anastassiou, E.D., Older, S.A., Tsokos, G.C., Nelson, D.L., Balow, J.E., Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription (1991) J Clin Invest, 87, pp. 1739-1747
• Mozo, L., Gayo, A., Suarez, A., Rivas, D., Zamorano, J., Gutierrez, C., Glucocorticoids inhibit IL-4 and mitogen-induced IL-4R alpha chain expression by different posttranscriptional mechanisms (1998) J Allergy Clin Immunol, 102, pp. 968-976
• So, E.Y., Kim, S.H., Park, H.H., Cho, B.S., Lee, C.E., Corticosteroid inhibits IL-4 signaling through down-regulation of IL-4 receptor and STAT6 activity (2002) FEBS Lett, 518, pp. 53-59
• Wu, C.Y., Wang, K., McDyer, J.F., Seder, R.A., Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness (1998) J Immunol, 161, pp. 2723-2730
• Mori, S., Murakami-Mori, K., Bonavida, B., Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines (1998) Anticancer Res, 18, pp. 4403-4408
• Hawrylowicz, C.M., Guida, L., Paleolog, E., Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes (1994) Immunology, 83, pp. 274-280
• Sapi, E., Flick, M.B., Gilmore-Hebert, M., Rodov, S., Kacinski, B.M., Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids (1995) Oncogene, 10, pp. 529-542
• Lee, H.C., Shibata, H., Ogawa, S., Maki, K., Ikuta, K., Transcriptional regulation of the mouse IL-7 receptor alpha promoter by glucocorticoid receptor (2005) J Immunol, 174, pp. 7800-7806
• Kovalovsky, D., Paez Pereda, M., Sauer, J., Perez Castro, C., Nahmod, V.E., Stalla, G.K., The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1 (1998) Eur J Immunol, 28, pp. 2075-2085
• Arzt, E., Sauer, J., Pollmacher, T., Labeur, M., Holsboer, F., Reul, J.M., Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin (1994) Endocrinology, 134, pp. 672-677
• Brown, E.A., Dare, H.A., Marsh, C.B., Wewers, M.D., The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1rII) in monocytes: a comparison to interleukin 1 beta (IL-1beta) and interleukin 1 receptor antagonist (IL-1ra) (1996) Cytokine, 8, pp. 828-836
• Visser, J., Nagelkerken, L., Expression of the IL-10 receptor on human monocytes is moderately suppressed by glucocorticoids (2002) Int Immunopharmacol, 2, pp. 1491-1493
• Visser, J.T., Sparing interleukin-10 receptor expression by glucocorticoids is a prerequisite for the synergistic immunosuppressive effects of interleukin-10 and glucocorticoids (2003) Transplantation, 76, pp. 1534-1535. , (author reply 1535)
• Romagnani, S., The Th1/Th2 paradigm (1997) Immunol Today, 18, pp. 263-266
• Glimcher, L.H., Murphy, K.M., Lineage commitment in the immune system: the T helper lymphocyte grows up (2000) Genes Dev, 14, pp. 1693-1711
• Liu, J., Beller, D.I., Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains (2003) J Immunol, 170, pp. 4489-4496
• Liberman, A.C., Refojo, D., Arzt, E., Cytokine signaling/transcription factor cross-talk in T-cell activation and Th1-Th2 differentiation (2003) Arch Immunol Ther Exp (Warsz), 51, pp. 351-365
• Refojo, D., Liberman, A.C., Giacomini, D., Carbia Nagashima, A., Graciarena, M., Echenique, C., Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells (2003) Ann NY Acad Sci, 992, pp. 196-204
• Kovalovsky, D., Refojo, D., Holsboer, F., Arzt, E., Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production (2000) J Neuroimmunol, 109, pp. 23-29
• Helmberg, A., Auphan, N., Caelles, C., Karin, M., Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor (1995) EMBO J, 14, pp. 452-460
• Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H., Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone (1990) Cell, 62, pp. 1189-1204
• Schule, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor (1990) Cell, 62, pp. 1217-1226
• Ray, A., Prefontaine, K.E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor (1994) Proc Natl Acad Sci USA, 91, pp. 752-756
• Wissink, S., van Heerde, E.C., vand der Burg, B., van der Saag, P.T., A dual mechanism mediates repression of NF-kappa B activity by glucocorticoids (1998) Mol Endocrinol, 12, pp. 355-363
• Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., Baldwin Jr., A.S., Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors (1995) Mol Cell Biol, 15, pp. 943-953
• Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids (1995) Mol Endocrinol, 9, pp. 401-412
• Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin Jr., A.S., Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids (1995) Science, 270, pp. 283-286
• Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis (1995) Science, 270, pp. 286-290
• Costas, M.A., Muller Igaz, L., Holsboer, F., Arzt, E., Transrepression of NF-kappa B is not required for glucocorticoid-mediated protection of TNF-alpha-induced apoptosis on fibroblasts (2000) Biochim Biophys Acta, 1499, pp. 122-129
• Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression (1994) J Biol Chem, 269, pp. 13289-13295
• Nissen, R.M., Yamamoto, K.R., The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain (2000) Genes Dev, 14, pp. 2314-2329
• Vacca, A., Felli, M.P., Farina, A.R., Martinotti, S., Maroder, M., Screpanti, I., Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements (1992) J Exp Med, 175, pp. 637-646
• Chen, R., Burke, T.F., Cumberland, J.E., Brummet, M., Beck, L.A., Casolaro, V., Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter (2000) J Immunol, 164, pp. 825-832
• Mori, A., Kaminuma, O., Suko, M., Inoue, S., Ohmura, T., Hoshino, A., Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids (1997) Blood, 89, pp. 2891-2900
• Jee, Y.K., Gilmour, J., Kelly, A., Bowen, H., Richards, D., Soh, C., Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment (2005) J Biol Chem, 280, pp. 23243-23250
• Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M.J., Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun (1995) J Biol Chem, 270, pp. 12548-12556
• Tao, Y., Williams-Skipp, C., Scheinman, R.I., Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis (2001) J Biol Chem, 276, pp. 2329-2332
• von Laue, S., Finidori, J., Maamra, M., Shen, X.Y., Justice, S., Dobson, P.R., Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone (2000) J Endocrinol, 165, pp. 301-311
• Bianchi, M., Meng, C., Ivashkiv, L.B., Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids (2000) Proc Natl Acad Sci USA, 97, pp. 9573-9578
• Biola, A., Andreau, K., David, M., Sturm, M., Haake, M., Bertoglio, J., The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes (2000) FEBS Lett, 487, pp. 229-233
• Lechner, J., Welte, T., Doppler, W., Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding (1997) Immunobiology, 198, pp. 112-123
• Pfitzner, E., Jahne, R., Wissler, M., Stoecklin, E., Groner, B., p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response (1998) Mol Endocrinol, 12, pp. 1582-1593
• Zhang, Z., Jones, S., Hagood, J.S., Fuentes, N.L., Fuller, G.M., STAT3 acts as a co-activator of glucocorticoid receptor signaling (1997) J Biol Chem, 272, pp. 30607-30610
• Aittomaki, S., Pesu, M., Groner, B., Janne, O.A., Palvimo, J.J., Silvennoinen, O., Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes (2000) J Immunol, 164, pp. 5689-5697
• Fahey, A.J., Robins, R.A., Kindle, K.B., Heery, D.M., Constantinescu, C.S., Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent (2006) J Leukoc Biol, 80, pp. 133-144
• Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y., Aringer, M., Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes (2000) J Immunol, 164, pp. 1768-1774
• Ramirez, F., Glucocorticoids induce a Th2 response in vitro (1998) Dev Immunol, 6, pp. 233-243
• Blotta, M.H., DeKruyff, R.H., Umetsu, D.T., Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes (1997) J Immunol, 158, pp. 5589-5595
• Zhang, D.H., Cohn, L., Ray, P., Bottomly, K., Ray, A., Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene (1997) J Biol Chem, 272, pp. 21597-21603
• Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment (2000) Cell, 100, pp. 655-669
• Costas, M., Trapp, T., Pereda, M.P., Sauer, J., Rupprecht, R., Nahmod, V.E., Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis (1996) J Clin Invest, 98, pp. 1409-1416
• Orti, E., Mendel, D.B., Smith, L.I., Munck, A., Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells (1989) J Biol Chem, 264, pp. 9728-9731
• Almlof, T., Wright, A.P., Gustafsson, J.A., Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor (1995) J Biol Chem, 270, pp. 17535-17540
• Webster, J.C., Jewell, C.M., Bodwell, J.E., Munck, A., Sar, M., Cidlowski, J.A., Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein (1997) J Biol Chem, 272, pp. 9287-9293
• Hittelman, A.B., Burakov, D., Iniguez-Lluhi, J.A., Freedman, L.P., Garabedian, M.J., Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins (1999) EMBO J, 18, pp. 5380-5388
• Rogatsky, I., Logan, S.K., Garabedian, M.J., Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase (1998) Proc Natl Acad Sci USA, 95, pp. 2050-2055
• Itoh, M., Adachi, M., Yasui, H., Takekawa, M., Tanaka, H., Imai, K., Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation (2002) Mol Endocrinol, 16, pp. 2382-2392
• Irusen, E., Matthews, J.G., Takahashi, A., Barnes, P.J., Chung, K.F., Adcock, I.M., p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma (2002) J Allergy Clin Immunol, 109, pp. 649-657
• Szatmary, Z., Garabedian, M.J., Vilcek, J., Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase (2004) J Biol Chem, 279, pp. 43708-43715
• DeFranco, D.B., Qi, M., Borror, K.C., Garabedian, M.J., Brautigan, D.L., Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors (1991) Mol Endocrinol, 5, pp. 1215-1228
• Rider, L.G., Hirasawa, N., Santini, F., Beaven, M.A., Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells (1996) J Immunol, 157, pp. 2374-2380
• Caelles, C., Gonzalez-Sancho, J.M., Munoz, A., Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway (1997) Genes Dev, 11, pp. 3351-3364
• Gonzalez, M.V., Gonzalez-Sancho, J.M., Caelles, C., Munoz, A., Jimenez, B., Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells (1999) FEBS Lett, 459, pp. 272-276
• Swantek, J.L., Cobb, M.H., Geppert, T.D., Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK (1997) Mol Cell Biol, 17, pp. 6274-6282
• Sakai, A., Han, J., Cato, A.C., Akira, S., Li, J.D., Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP kinase phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells (2004) BMC Mol Biol, 5, p. 2
• Biola, A., Lefebvre, P., Perrin-Wolff, M., Sturm, M., Bertoglio, J., Pallardy, M., Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5), but not AP-1 (2001) Mol Endocrinol, 15, pp. 1062-1076
• Lasa, M., Abraham, S.M., Boucheron, C., Saklatvala, J., Clark, A.R., Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 (2002) Mol Cell Biol, 22, pp. 7802-7811
• Orphanides, G., Reinberg, D., RNA polymerase II elongation through chromatin (2000) Nature, 407, pp. 471-475
• Margueron, R., Trojer, P., Reinberg, D., The key to development: interpreting the histone code? (2005) Curr Opin Genet Dev, 15, pp. 163-176
• Orphanides, G., Reinberg, D., A unified theory of gene expression (2002) Cell, 108, pp. 439-451
• Takemoto, N., Arai, K., Miyatake, S., Cutting edge: the differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 development (2002) J Immunol, 169, pp. 4103-4107
• Shoemaker, J., Saraiva, M., O'Garra, A., GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells (2006) J Immunol, 176, pp. 3470-3479
• Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B.S., Huang, S., HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription (2006) Mol Cell, 22, pp. 669-679
• Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J., Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappa B suppression (2006) J Exp Med, 203, pp. 7-13
• Glass, C.K., Rosenfeld, M.G., The coregulator exchange in transcriptional functions of nuclear receptors (2000) Genes Dev, 14, pp. 121-141
• Ostlund Farrants, A.K., Blomquist, P., Kwon, H., Wrange, O., Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex (1997) Mol Cell Biol, 17, pp. 895-905
• Fletcher, T.M., Xiao, N., Mautino, G., Baumann, C.T., Wolford, R., Warren, B.S., ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling (2002) Mol Cell Biol, 22, pp. 3255-3263
• Deroo, B.J., Archer, T.K., Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin (2001) Mol Biol Cell, 12, pp. 3365-3374
• Carbia-Nagashima, A., Arzt, E., Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling (2004) IUBMB Life, 56, pp. 83-88
• Bossis, G., Malnou, C.E., Farras, R., Andermarcher, E., Hipskind, R., Rodriguez, M., Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation (2005) Mol Cell Biol, 25, pp. 6964-6979
• Gill, G., Something about SUMO inhibits transcription (2005) Curr Opin Genet Dev, 15, pp. 536-541
• Le Drean, Y., Mincheneau, N., Le Goff, P., Michel, D., Potentiation of glucocorticoid receptor transcriptional activity by sumoylation (2002) Endocrinology, 143, pp. 3482-3489
• Desterro, J.M., Rodriguez, M.S., Hay, R.T., SUMO-1 modification of IkappaBalpha inhibits NF-kappa B activation (1998) Mol Cell, 2, pp. 233-239

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------